- Oscar Health, Inc. (OSCR, Financial) reports a significant 42% revenue increase in Q1 2025, driven by rising membership numbers.
- Analysts set a one-year target price range between $8.00 and $28.00, with an average forecasted upside of 8.99%.
- Oscar Health maintains a "Hold" recommendation from the consensus of brokerage firms.
Oscar Health, Inc. (OSCR) recently unveiled its first-quarter 2025 financial results, showcasing remarkable growth. The company reported a 42% revenue surge to $3 billion, fueled by a substantial 41% increase in membership. Furthermore, net income rose to $275 million, marking an impressive $98 million improvement. Oscar Health confidently reaffirms its optimistic financial outlook for 2025, supported by a robust cash position of $4.9 billion.
Wall Street Analysts' Insights
According to projections from nine analysts, the average target price for Oscar Health Inc. (OSCR, Financial) stands at $18.28, with estimates ranging from a high of $28.00 to a low of $8.00. This average suggests a potential upside of 8.99% from the current share price of $16.77. For a more comprehensive view of these estimates, visit the Oscar Health Inc (OSCR) Forecast page.
The consensus recommendation from nine brokerage firms positions Oscar Health Inc. (OSCR, Financial) at an average rating of 2.8, which corresponds to a "Hold" status. This rating is part of a scale where 1 represents a Strong Buy and 5 indicates a Sell.
According to GuruFocus, the estimated GF Value for Oscar Health Inc. (OSCR, Financial) in the upcoming year is $18.77, implying a potential upside of 11.93% from the current price of $16.77. The GF Value is GuruFocus' determination of the stock's fair trading value, calculated through historical trading multiples, past business growth, and future performance estimates. For further insights, explore the Oscar Health Inc (OSCR) Summary page.
